AJ

Amar Jeet Singh

Active Director Additional Director DIN 03266348
DIN 03266348 First appointment Aug 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Aug 2011
Shareholding value •••• Premium profile

About Amar Jeet Singh

Data last updated:

Amar Jeet Singh is an Additional Director at Ventis Pharmaceuticals Private Limited (since 2015) and Director at Intellect Adworks Private Limited (since 2014). The companies operate in Pharma, Infrastructure and Utilities and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹29.55 Cr; the largest is Ventis Pharmaceuticals Private Limited at ₹29.55 Cr (FY 2025). Earlier, Amar Jeet Singh was a Director at Intellect Healthcare Private Limited (2011) and Director at Cootie Infra Tech Private Limited (2011–2012) and 2 more.

DIN 03266348
Primary Designation Additional Director
Industry Pharma
First Appointment 27 Aug 2011
Oldest Company Age 18 yrs
Largest company Ventis Pharmaceuticals Private Limited · ₹29.55 Cr (FY 2025)
Combined revenue ₹29.55 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director05 Nov 20152013₹29.55 Cr (FY 2025)Active
Intellect Adworks Private Limited U74300DL2007PTC172051
Director15 Jan 20142007₹2,500 (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Intellect Healthcare Private Limited U24232DL2007PTC171881
Director27 Aug 20112007Strike Off
Cootie Infra Tech Private Limited U74910DL2007PTC171885
Director27 Aug 20112007Active
Director27 Aug 20112008₹13.2 Lakh (FY 2016)Strike Off
Director27 Aug 20112007Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Amar Jeet Singh

Directorship timeline

Open interactive timeline →
Ventis Pharmaceuticals Private Limited
Intellect Adworks Private Limited
Intellect Healthcare Private Limited
Cootie Infra Tech Private Limited
Premium access

Shareholding and investment profile for Amar Jeet Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amar Jeet Singh

Amar Jeet Singh currently holds 2 directorships: Ventis Pharmaceuticals Private Limited (Additional Director, since 05 Nov 2015, revenue ₹29.55 Cr (FY 2025)); Intellect Adworks Private Limited (Director, since 15 Jan 2014, revenue ₹2,500 (FY 2024)).

Amar Jeet Singh was first appointed on 27 Aug 2011 as Director at Intellect Healthcare Private Limited. The most recent appointment on record is 05 Nov 2015 at Ventis Pharmaceuticals Private Limited.

The 2 current companies of Amar Jeet Singh that report revenue have a combined latest revenue of ₹29.55 Cr: Ventis Pharmaceuticals Private Limited ₹29.55 Cr (FY 2025); Intellect Adworks Private Limited ₹2,500 (FY 2024).

Amar Jeet Singh held 4 earlier board appointments: Intellect Healthcare Private Limited (Director, 27 Aug 2011 to 02 Dec 2011); Cootie Infra Tech Private Limited (Director, 27 Aug 2011 to 10 Sep 2012); Intellect Vivid Exim Services Private Limited (Director, 27 Aug 2011 to 10 Sep 2012); Exhilarate Technologies And Consulting Private Limited (Director, 27 Aug 2011 to 02 Dec 2011).

The current boards of Amar Jeet Singh's companies include Manish Aggarwal (Ventis Pharmaceuticals Private Limited), Renu Sharma (Intellect Adworks Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available